Positive Peritoneal Cytology as a Predictor of Prognosis in Early Stage of Endometrioid Adenocarcinoma

Abstract

Background: Peritoneal cytology has been reported to be an independent risk factor for poor survival, but it is not included in the current international federation of gynecology and obstetrics (FIGO) staging system for risk stratification.

Sonographic Presentation of Endometrial Carcinoma Stage I: A Case Study

“…6 Histologically, the most common type of endometrial carcinoma is endometrioid adenocarcinoma, also known as endometrial carcinoma type 1. 1,5 This type of tumor develops from the epithelial cells found in the endometrial glands. Nonendometrioid carcinoma, also known as type II endometrial carcinoma, resembles clear cell or ovarian serous adenocarcinoma.…”

“…The five-year survival rate in patients with Stage I endometrial carcinoma is 95%. 1 Satisfactory prognosis decreases in those patients with advanced or recurrent tumors. The five-year survival rate of endometrial carcinoma for patients with Stage III is 59.6%.…”

“…Routine clinical follow-up is recommended to patients with a history of endometrial carcinoma for the management and recurrence of the disease. 1,13…”

“…Reports indicate that about 40 100 new cases were diagnosed in 2008, and 52 630 new cases were diagnosed in 2014 in the United States. [1][2][3] This malignant disease affects approximately 1 in every 50 women, with most of the cases presenting in postmenopausal women. 1 Endometrial carcinoma has an unknown etiology.…”

“…[1][2][3] This malignant disease affects approximately 1 in every 50 women, with most of the cases presenting in postmenopausal women. 1 Endometrial carcinoma has an unknown etiology. The most common clinical sign is abnormal uterine bleeding.…”